New drug aims to stop deadly clots in pancreatic cancer patients
Prevention
Recruiting now
This study is testing if a drug called Kinisoquin™ can prevent dangerous blood clots in people with advanced pancreatic cancer who are starting chemotherapy. About 480 patients will receive either the study drug or a placebo for 16 weeks to see which group has fewer clots. The go…
Phase: PHASE3 • Sponsor: Quercis Pharma AG • Aim: Prevention
Last updated Mar 17, 2026 13:09 UTC